Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Tools & Techniques

Tools & Techniques Cancer

The Rise of ctDNA, Part Two

| Michael Schubert

Circulating tumor DNA profiling can yield new insights into early-stage lung cancer evolution.

Tools & Techniques Cancer

The Rise of ctDNA, Part One

| Roisin McGuigan

New ctDNA assays could make more metastatic melanoma cases detectable.

Tools & Techniques Cancer

Cracking Cancer’s Code

| Roisin McGuigan

Sitting Down With George Calin, Professor, The University of Texas MD Anderson Cancer Center, USA.

Tools & Techniques Cell & gene therapy

Small(er) Sequence, Big(ger) Promise

| Ruth Steer

CRISPR gene editing with a newly characterized orthologue may bring the approach closer to the clinic.

Tools & Techniques Cancer

A Winning Combination?

| Roisin McGuigan

Engineering more effective antibody-drug conjugates.

Tools & Techniques Animal models

An End to Animal Testing is Not Yet in Sight

| Sandy Mackay, Bella Williams

We need alternatives but, right now, in vivo methods might be the best option we have

Tools & Techniques Microbiology

How Are You – and How’s Your Microbiome?

| Pratik Jagtap

Analyzing our 'second genome' could be the key to improving healthcare

Tools & Techniques Drug delivery

Pharmtastic Voyage

| James Strachan

A microscopic submarine helps deliver drugs to the stomach

Tools & Techniques Diagnostics & prognostics

We Must Guide POCT

| Xavier Navarro

Point-of-care testing is a valuable resource that we need to bolster with high standards

Tools & Techniques Analytical science

NoBody’s Fool

| Joanna Cummings

Advanced mass spectrometry uncovers a tiny protein with important implications

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register